Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide, with limited therapeutic options and poor long-term survival.
Hypericum japonicum Thunb.
(Tianjihuang), a traditional Chinese medicine exhibits promising anticancer properties.
This study aims to elucidate the multi-target mechanisms of Tianjihuang in treating HCC using network pharmacology and molecular docking techniques.
